|4Jul 5, 9:08 PM ET

Gauthier George 4

4 · IGM Biosciences, Inc. · Filed Jul 5, 2023

Insider Transaction Report

Form 4
Period: 2023-07-03
Gauthier George
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2023-07-03$9.42/sh936$8,81840,017 total
Footnotes (2)
  • [F1]The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan, entered into on December 29, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • [F2]This transaction was executed in multiple trades at prices ranging from $9.22 to $9.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION